BridgeMD
New treatment option for Stroke
Official title Effects on Subacute Stroke With Robotic Assistive Gait Training
ClinicalTrials.gov ID: NCT07040215
What this study is testing
- What it's testing
- The goal of this randomized controlled trial is to learn about the effects of Robotic Assisted Gait Training (RAGT) combined with traditional physical therapy in subacute stroke patients. The main question it aims to answer is: \- Does RAGT combined with traditional physical therapy improve gait and functional performance in subacute stroke patients compared to traditional physical therapy alone?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 70
You may be able to join if
- Diagnosed with stroke (ischemic or hemorrhagic) confirmed by medical imaging.
- Subacute phase of stroke (onset within 1 to 3 months).
- Moderate to good standing balance ability.
- Sufficient cognitive ability to understand the study and follow instructions.
- Able to participate in rehabilitation training during the study period.
You likely can't join if
- Body weight over 90 kg.
- Presence of other neurological disorders.
- Severe cardiovascular disease or other health conditions affecting mobility.
- Significant lower limb pain, joint contracture, or spasticity (Modified Ashworth Scale score \> 3) that impairs walking.
- Diagnosed with cardiopulmonary disease that contraindicates exercise training.
- Cognitive impairment that prevents understanding of training instructions or completion of questionnaires.
See the full eligibility criteria
- Diagnosed with stroke (ischemic or hemorrhagic) confirmed by medical imaging.
- Subacute phase of stroke (onset within 1 to 3 months).
- Moderate to good standing balance ability.
- Sufficient cognitive ability to understand the study and follow instructions.
- Able to participate in rehabilitation training during the study period.
- Body weight over 90 kg.
- Presence of other neurological disorders.
- Severe cardiovascular disease or other health conditions affecting mobility.
- Significant lower limb pain, joint contracture, or spasticity (Modified Ashworth Scale score \> 3) that impairs walking.
- Diagnosed with cardiopulmonary disease that contraindicates exercise training.
- Cognitive impairment that prevents understanding of training instructions or completion of questionnaires.
- Inability to complete the rehabilitation training protocol.
The study team makes the final eligibility decision.
Where it's taking place
- Changhua, Taiwan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changhua, Taiwan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.